Nurigra Chewable Tablet in Healthy Adult Male Volunteers

NCT01651858 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2012-07-27

No results posted yet for this study

Summary

The purpose of this study is to evaluate pharmacokinetics of sildenafil citrate in healthy male volunteers.

Conditions

  • Healthy

Interventions

DRUG

Nurigra Chewable tablet

1 tablet of 100mg, once a day

Sponsors & Collaborators

  • Daewoong Pharmaceutical Co. LTD.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-02-29
Completion
2012-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01651858 on ClinicalTrials.gov